- Home
- ABTS vs ACON Comparison
ABTS vs ACON Comparison
Compare ABTS & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- ACON
- Stock Information
- Founded
- ABTS 2010
- ACON 2008
- Country
- ABTS Hong Kong
- ACON United States
- Employees
- ABTS N/A
- ACON N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- ABTS Technology
- ACON Technology
- Exchange
- ABTS Nasdaq
- ACON Nasdaq
- Market Cap
- ABTS 4.6M
- ACON 4.8M
- IPO Year
- ABTS N/A
- ACON 2022
- Fundamental
- Price
- ABTS $2.56
- ACON $7.03
- Analyst Decision
- ABTS
- ACON Buy
- Analyst Count
- ABTS 0
- ACON 2
- Target Price
- ABTS N/A
- ACON $481.00
- AVG Volume (30 Days)
- ABTS 30.6K
- ACON 51.2K
- Earning Date
- ABTS 12-31-2024
- ACON 05-14-2025
- Dividend Yield
- ABTS N/A
- ACON N/A
- EPS Growth
- ABTS N/A
- ACON N/A
- EPS
- ABTS N/A
- ACON N/A
- Revenue
- ABTS $6,711,225.00
- ACON $45,724.00
- Revenue This Year
- ABTS N/A
- ACON $212.31
- Revenue Next Year
- ABTS N/A
- ACON N/A
- P/E Ratio
- ABTS N/A
- ACON N/A
- Revenue Growth
- ABTS 299.11
- ACON N/A
- 52 Week Low
- ABTS $0.25
- ACON $6.20
- 52 Week High
- ABTS $4.19
- ACON $3,500.42
- Technical
- Relative Strength Index (RSI)
- ABTS 49.38
- ACON 33.65
- Support Level
- ABTS $2.28
- ACON $6.20
- Resistance Level
- ABTS $3.10
- ACON $7.54
- Average True Range (ATR)
- ABTS 0.44
- ACON 0.65
- MACD
- ABTS -0.03
- ACON 3.52
- Stochastic Oscillator
- ABTS 38.64
- ACON 23.21
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.